Table 1 Age, pathologic stage, and PD-L1 expression in OCCC and ECCC cases with MMR intact and MMR-D status
OCCC | ECCC | ||||||
|---|---|---|---|---|---|---|---|
MMR-D | MMR intact | total | MMR-D | MMR intact | total | ||
Age (mean ± SD) | 45.5 ± 7.8 | 52.18 ± 9.57 | 51.15 ± 9.63 | 35 | 64.62 ± 10.97 | 63.44 ± 12.21 | |
Pathologic stage(FIGO) | |||||||
I | 3 | 11 | 14 | 0 | 7 | 7 | |
II | 0 | 6 | 6 | 0 | 7 | 7 | |
III | 1 | 5 | 6 | 1 | 3 | 4 | |
IV | 0 | 0 | 0 | 0 | 0 | 0 | |
NA | 0 | 2 | 2 | 0 | 10 | 10 | |
PDL1 expression | |||||||
Tumor cells | 3 | 13 | 16 | 1 | 19 | 20 | |
Inflammatory cells | 3 | 8 | 11 | 1 | 24 | 25 | |
Total (either tumor or inflammatory cells) | 4 | 14 | 18 | 1 | 24 | 25 | |